Wart war: blood clot vs vitamin jab – which works best?
NCT ID NCT07543926
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two injection treatments for common warts: one using a patient's own blood components (platelet-rich fibrin) and the other using vitamin D. About 70 adults with warts will receive one of the two injections. The goal is to see which treatment shrinks warts more and keeps them from coming back.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMON WARTS (VERRUCA VULGARIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sohag University
Sohag, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blister beetle extract banish common warts? phase 3 trial investigates
- New hope for stubborn warts: extended treatment shows promise
- Wart war: vitamin D3 or acyclovir injections – which works better?
- New gel could zap away common warts in just weeks
- Could a yeast extract injection finally banish common warts?